✦ LIBER ✦
Time to first tumor progression as a predictor of efficacy of continued treatment with trastuzumab beyond progression in human epidermal growth factor receptor 2-positive metastatic breast cancer
✍ Scribed by Mitsuhiro Hayashi; Yasuhiro Okumura; Tomofumi Osako; Yasuo Toyozumi; Nobuyuki Arima; Hirotaka Iwase; Reiki Nishimura
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 215 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1341-9625
No coin nor oath required. For personal study only.